| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2000 | 2015 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.040 | None | 1.000 | 4 | 2 | 1997 | 2016 | ||||||||
|
transporter 1, ATP binding cassette subfamily B member | 0.500 | 0.808 | 5.3E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 2 | 1997 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 1999 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2016 | ||||||||
|
C-C motif chemokine ligand 4 | 0.466 | 0.923 | 0.24 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2016 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2013 | ||||||||
|
lysosomal associated membrane protein 3 | 0.560 | 0.692 | 2.7E-04 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2012 | ||||||||
|
limbic system associated membrane protein | 0.558 | 0.654 | 0.99 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
SEC14 like lipid binding 2 | 0.494 | 0.885 | 2.9E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2016 | ||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | 0.475 | 0.769 | 8.4E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2012 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2012 | 2020 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2015 | 2019 | |||||||||
|
nuclear RNA export factor 1 | 0.531 | 0.885 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2016 | ||||||||
|
TIR domain containing adaptor protein | 0.604 | 0.769 | 7.6E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2010 | 2014 | ||||||||
|
GTP binding protein overexpressed in skeletal muscle | 0.467 | 0.769 | 1.2E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2012 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2018 | ||||||||
|
interleukin 5 | 0.437 | 0.846 | 5.7E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2012 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
USO1 vesicle transport factor | 0.522 | 0.885 | 0.33 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2016 | ||||||||
|
interleukin 17F | 0.480 | 0.808 | 3.9E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2016 | 2019 | ||||||||
|
thymocyte selection associated | 0.682 | 0.654 | 2.0E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2017 |